Morbidity and quality of life of totally laparoscopic versus laparoscopy-assisted distal gastrectomy for early gastric cancer: a multi-center prospective randomized controlled trial (CKLASS01)
Gastric Cancer · 2025
DOI: 10.1007/s10120-024-01561-y ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Gastric Cancer, 2025. Verfasst von Yu Zhang und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastrectomy, Quality of Life, Laparoscopy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Clinical Research Plan of SHDC.
Abstract (Originalsprache)
BACKGROUND: There is a paucity of confirmatory randomized controlled trials (RCTs) comparing the effectiveness of totally laparoscopic distal gastrectomy (TLDG) vs laparoscopy-assisted distal gastrectomy (LADG) for early gastric cancer (EGC). METHODS: A phase III, prospective, multi-center RCT was conducted, wherein patients (n = 442) with clinical stage I gastric cancer eligible for laparoscopic distal gastrectomy were randomized 1:1 to the TLDG or the LADG group. Postoperative morbidity and quality of life (QoL) were compared. RESULTS: In total, 422 patients were assessed (TLDG, 216; LADG, 206) in the modified intention-to-treat (mITT) analysis. The morbidity rate did not differ significantly between the two groups (TLDG, 6.0%; LADG, 5.8%; P = 0.93). The 90-day mortality rate was comparable between the groups (TLDG, 0.5%; LADG, 0.0%; P > 0.99). TLDG was significantly associated with a lower pain score compared with LADG in patients with a BMI of ≥ 25 kg/m2 (P = 0.002) at 24 h postoperatively. Moreover, TLDG significantly improved QoL in terms of C30 social functioning at 3 and 6 months (P = 0.03 and P = 0.04), C30 global health status at 3 months (P = 0.02), and STO22 body image at 3 months (P = 0.01), with differences dissipating at 12 months. CONCLUSIONS: TLDG is not superior to LADG in terms of postoperative morbidity and mortality, but it provides better C30 social functioning at 3 and 6 months, C30 global health status and STO22 body image at 3 months, and reduces early postoperative pain for patients with a BMI of ≥ 25 kg/m2. TRIAL REGISTRATION: ClinicalTrials.gov: NCT03393182.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, People's Republic of China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, People's Republic of China.
- Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's…
- Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
- Division of Foregut Surgery, Korea University College of Medicine, Seoul, Republic of Korea.
Förderung
- National Natural Science Foundation of China
- Clinical Research Plan of SHDC
Zitieren
APA
Zhang, Y., Li, Z., Tian, Y., Yu, J., Wang, J., Lee, C., Wang, K., He, X., Qiao, Q., Ji, G., Xu, Z., Yang, L., Xu, H., Du, X., Su, X., Xing, J., Niu, Z., Zhu, L., Yan, S., …, & China-Korea Laparoscopic Gastrointestinal Surgery Study (CKLASS) Cooperative Group (2025). Morbidity and quality of life of totally laparoscopic versus laparoscopy-assisted distal gastrectomy for early gastric cancer: a multi-center prospective randomized controlled trial (CKLASS01). Gastric Cancer. https://doi.org/10.1007/s10120-024-01561-y
Vancouver
Zhang Y, Li Z, Tian Y, Yu J, Wang J, Lee C, et al. Morbidity and quality of life of totally laparoscopic versus laparoscopy-assisted distal gastrectomy for early gastric cancer: a multi-center prospective randomized controlled trial (CKLASS01). Gastric Cancer. 2025. doi:10.1007/s10120-024-01561-y
BibTeX
@article{Zhang2025,
author = {Zhang, Yu and Li, Ziyu and Tian, Yantao and Yu, Jiang and Wang, Jieti and Lee, Changmin and Wang, Kuan and He, Xianli and Qiao, Qing and Ji, Gang and Xu, Zekuan and Yang, Li and Xu, Hao and Du, Xiaohui and Su, Xiangqian and Xing, Jiadi and Niu, Zhaojian and Zhu, Linghua and Yan, Su and Li, Yong and Wang, Junjiang and Li, Zhengrong and Zhao, Yongliang and You, Jun and Jing, Changqing and Fan, Lin and Du, Yian and Zhao, Gaoping and Song, Wu and Xuan, Yi and Zang, Mingde and Chen, Jie and Park, Sungsoo and Huang, Hua and China-Korea Laparoscopic Gastrointestinal Surgery Study (CKLASS) Cooperative Group, China-Korea Laparoscopic Gastrointestinal Surgery Study (CKLASS) Cooperative Group},
title = {Morbidity and quality of life of totally laparoscopic versus laparoscopy-assisted distal gastrectomy for early gastric cancer: a multi-center prospective randomized controlled trial (CKLASS01)},
journal = {Gastric Cancer},
year = {2025},
doi = {10.1007/s10120-024-01561-y}
}
EUVIMED